• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. DYNASTY A-CLASS 38MM STD GROUP E CROSSLINKED POL; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. DYNASTY A-CLASS 38MM STD GROUP E CROSSLINKED POL; HIP COMPONENT Back to Search Results
Model Number DLXPGE38
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Information (3190)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event will be updated once the investigation is complete.Trends will be evaluate.
 
Event or Problem Description
Allegedly, patient was revised for liner dissociation.Time to revision was 63 months additional information: indication for surgery was polyethylene failure.Bmi was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNASTY A-CLASS 38MM STD GROUP E CROSSLINKED POL
Common Device Name
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key10319640
Report Number3010536692-2020-00499
Device Sequence Number16910399
Product Code LZO
UDI-Device IdentifierM684DLXPGE381
UDI-PublicM684DLXPGE381
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K061547
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 10/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Model NumberDLXPGE38
Device Catalogue NumberDLXPGE38
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/01/2020
Initial Date Received by Manufacturer 07/01/2020
Supplement Date Received by Manufacturer07/01/2020
Initial Report FDA Received Date07/24/2020
Supplement Report FDA Received Date10/29/2020
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age39 YR
-
-